Aliases & Classifications for Dysentery

MalaCards integrated aliases for Dysentery:

Name: Dysentery 12 42 14 69
Infectious Diarrhea 12 52

Classifications:



Summaries for Dysentery

Disease Ontology : 12 An intestinal infectious disease that involves inflammation of the intestines, especially colon, due to chemical irritants, bacteria, protozoa, or parasitic worms, which results in severe diarrhea with passage of mucus and blood.

MalaCards based summary : Dysentery, also known as infectious diarrhea, is related to shigellosis and typhoid fever, and has symptoms including diarrhea An important gene associated with Dysentery is TF (Transferrin). The drugs Omeprazole and Azithromycin have been mentioned in the context of this disorder. Affiliated tissues include colon, testes and liver.

Wikipedia : 72 Dysentery is a type of gastroenteritis that results in diarrhea with blood. Other symptoms may include... more...

Related Diseases for Dysentery

Diseases related to Dysentery via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 231)
id Related Disease Score Top Affiliating Genes
1 shigellosis 32.0 CD40LG CD79A HP
2 typhoid fever 29.6 ALB CD40LG CD79A
3 lymphoma 29.5 ALB CD40LG CD79A
4 malaria 28.8 ALB CD40LG CRP HP IL1A
5 protozoal dysentery 12.0
6 amebiasis 11.9
7 balantidiasis 11.4
8 campylobacteriosis 10.9
9 midface dysplasia 10.8 ALB TTR
10 early-onset severe reducing body myopathy, x-linked 10.8 ALB TTR
11 capillary leak syndrome 10.8 ALB CRP
12 acquired hemophilia 10.8 CRP HP
13 poems syndrome 10.8 CRP TF
14 bacteriuria 10.7 TF TTR
15 chronic lymphocytic leukemia 10.7 HP TTR
16 cataract 10.7 ALB TTR
17 diverticulitis of colon 10.7 CRP ENO2
18 urethral gland abscess 10.7 CRP ENO2
19 harp syndrome 10.7 CRP TF
20 macular dystrophy, patterned, 1 10.6 TF TTR
21 middle ear carcinoma 10.6 ALB CD40LG
22 atopic dermatitis 5 10.6 ALB CD79A
23 intramuscular hemangioma 10.6 ALB CRP TF
24 ovary transitional cell carcinoma 10.6 ALB CD79A
25 female infertility of uterine origin 10.6 ALB TF TTR
26 epstein-barr virus hepatitis 10.6 CRP IL1A
27 estrogen excess 10.6 ALB CD40LG
28 speech and communication disorders 10.6 ALB CRP TTR
29 milker's nodule 10.6 ALB CRP TTR
30 hyperpigmentation of eyelid 10.6 ALB HP TF
31 fragile x syndrome type 2 10.6 ALB CD40LG
32 diphtheritic cystitis 10.6 CD79A CRP
33 acquired polycythemia 10.6 CD40LG CRP
34 non-congenital cyst of kidney 10.6 ALB CD79A
35 cannabis dependence 10.5 CD40LG CRP
36 endocervical type cervical mucinous adenocarcinoma 10.5 ALB CRP ENO2
37 infertility 10.5 ALB HP TTR
38 infertility due to extratesticular cause 10.5 ALB CD79A
39 hypervitaminosis a 10.5 CD79A TTR
40 anogenital venereal wart 10.5 ALB CRP TTR
41 maple bark strippers' lung 10.5 CRP IL1A
42 hypertensive heart disease 10.5 CD40LG CRP
43 necrobiosis lipoidica 10.5 CD79A TTR
44 xeroderma pigmentosum, group f 10.5 HP TF
45 motor neuron disease 10.5 CD40LG ENO2
46 childhood choroid plexus cancer 10.5 ENO2 IER3IP1
47 rocky mountain spotted fever 10.5 CD40LG CRP
48 brachial plexus neuritis 10.5 ENO2 IER3IP1
49 cryptogenic organizing pneumonia 10.5 ALB CRP
50 amyloidosis nodular localized cutaneous 10.5 CRP TTR

Comorbidity relations with Dysentery via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Dysentery:



Diseases related to Dysentery

Symptoms & Phenotypes for Dysentery

UMLS symptoms related to Dysentery:


diarrhea

Drugs & Therapeutics for Dysentery

Drugs for Dysentery (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 125)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
2
Azithromycin Approved Phase 4 83905-01-5 55185 53477736 447043
3
Loperamide Approved Phase 4,Phase 3 53179-11-6 3955
4
Rifaximin Approved, Investigational Phase 4,Phase 2,Phase 3 80621-81-4 6436173
5
Mebendazole Approved, Vet_approved Phase 4 31431-39-7 4030
6
Piperazine Approved, Vet_approved Phase 4 110-85-0 4837
7
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613 2171
8 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3
9 Anti-Infective Agents Phase 4,Phase 2,Phase 3
10 Antiparasitic Agents Phase 4,Phase 3,Phase 2
11 Antacids Phase 4,Phase 1
12 Anti-Ulcer Agents Phase 4,Phase 1
13 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Phase 1
14
Proton pump inhibitors Phase 4
15 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3
16 Antidiarrheals Phase 4,Phase 3
17 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3
18 rifamycin SV Phase 4,Phase 2,Phase 3
19 Rifamycins Phase 4,Phase 2,Phase 3
20 Anthelmintics Phase 4
21 Antimitotic Agents Phase 4
22 Piperazine citrate Phase 4
23 Amoxicillin-Potassium Clavulanate Combination Phase 4
24 Antitubercular Agents Phase 4,Phase 3
25 beta-Lactamase Inhibitors Phase 4
26 Clavulanic Acid Phase 4
27 Acidophilus Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2
28 Cola Nutraceutical Phase 4
29 Citrate Nutraceutical Phase 4
30
Citric Acid Nutraceutical, Vet_approved Phase 4 77-92-9 311
31
Ciprofloxacin Approved, Investigational Phase 3,Phase 2 85721-33-1 2764
32
Iron Approved Phase 3,Phase 2 7439-89-6 23925
33
Zinc Approved Phase 3,Phase 2 7440-66-6 32051 23994
34 Zinc sulfate Approved Phase 3 7733-02-0
35
Nitazoxanide Approved, Investigational, Vet_approved Phase 3,Phase 2 55981-09-4 41684
36
Lactulose Approved Phase 2, Phase 3 4618-18-2 11333
37
Irinotecan Approved, Investigational Phase 3 97682-44-5, 100286-90-6 60838
38
Terlipressin Approved, Investigational Phase 3 14636-12-5 72081
39
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
40
leucovorin Approved, Nutraceutical Phase 3 58-05-9 143 6006
41
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3 11103-57-4, 68-26-8 445354
42 Cytochrome P-450 CYP1A2 Inhibitors Phase 3,Phase 2
43 Cytochrome P-450 Enzyme Inhibitors Phase 3,Phase 2
44 Topoisomerase Inhibitors Phase 3,Phase 2
45 Antirheumatic Agents Phase 3,Phase 2,Phase 1
46 Antibodies Phase 3
47 Immunoglobulins Phase 3
48 Vaccines Phase 3,Phase 1,Phase 2
49 Micronutrients Phase 3,Phase 2
50 Trace Elements Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 95)

id Name Status NCT ID Phase Drugs
1 New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management– Surveillance Study for Adverse Effects Completed NCT00490932 Phase 4 Hypo-osmolar ORS
2 Effects of Gastric Acid on Colonic Microbiome Completed NCT01901276 Phase 4 Omeprazole 40 mg bid
3 Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea Completed NCT00359970 Phase 4 Azithromycin 500 mg;Azithromycin 1000 mg;Loperamide
4 Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea Completed NCT00292344 Phase 4 Rifaximin and loperamide
5 Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population Completed NCT02385058 Phase 4 Mebendazole;Quinfamide;Placebo
6 Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children Recruiting NCT02765217 Phase 4 Lactobacillus reuteri DSM 17938;Placebo;Amoxicillin-Clavulanic Acid
7 Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial Recruiting NCT02871908 Phase 4 Lactobacillus reuteri DSM 17938;Placebo
8 Improving Bowel Habits of Elderly With Probiotics and Non-probiotics Not yet recruiting NCT02949882 Phase 4
9 Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea Terminated NCT01972932 Phase 4
10 Probiotics and the Prevention of Traveler's Diarrhea Terminated NCT01005849 Phase 4
11 Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea Withdrawn NCT00875875 Phase 4 Rifaximin
12 Randomized Controlled Field Trial of a Probiotics to Assess Its Role in Preventig Diarrhoea Unknown status NCT00534170 Phase 3
13 Efficacy of Rifaximin in Preventing Campylobacteriosis Completed NCT02280044 Phase 2, Phase 3
14 Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea Completed NCT01208922 Phase 3 Rifamycin SV MMX;Ciprofloxacin
15 Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel Completed NCT00368316 Phase 3
16 Impact of Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly Prevalent Completed NCT00530374 Phase 3
17 Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal Completed NCT00109551 Phase 3 zinc sulphate dietary supplement;iron sulphate-folic acid dietary supplement
18 Fermented Milk and Fermented Rice on the Appearance of Respiratory and Gastrointestinal Symptoms Completed NCT01909128 Phase 3
19 Vitamin A Supplementation in Newborns Study Completed NCT00114868 Phase 3 Vitamin A
20 Zinc Supplementation in Shigella Patients Completed NCT00321126 Phase 3 Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks.
21 Study of Nitazoxanide in the Treatment of Amebiasis in Children Completed NCT00366730 Phase 3 Nitazoxanide
22 Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents Completed NCT00366236 Phase 3 Nitazoxanide
23 Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD) Completed NCT01142089 Phase 3 Placebo;Rifamycin SV MMX
24 Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study Completed NCT00993681 Phase 3
25 Rifaximin for Prevention of Travellers' Diarrhea Completed NCT00742469 Phase 3 Rifaximin;Placebo
26 Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults Completed NCT00737412 Phase 3
27 Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S. Completed NCT00328380 Phase 3 Rifaximin
28 Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy Recruiting NCT02464124 Phase 2, Phase 3 Nitazoxanide;Lactulose
29 Prevention of Irinotecan Induced Diarrhea by Probiotics Recruiting NCT02819960 Phase 3 PROBIO-FIX INUM®;Placebo
30 Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial Not yet recruiting NCT02473341 Phase 3 Bovine Colostrum;Placebo
31 A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea. Terminated NCT02920242 Phase 3 Rifaximin (Sandoz GmbH) tablet;Rifaximin (Xifaxan);Placebo
32 A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea Terminated NCT00466635 Phase 3 GT267-004 (tolevamer potassium sodium)
33 Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea Withdrawn NCT02736539 Phase 3 CBS 2004 (galacto-oligosaccharides);Placebo
34 A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans Unknown status NCT01243437 Phase 2 ciprofloxacin;doxyxcycline
35 Probiotics for Infectious Diarrhea in Children in South India Completed NCT01130792 Phase 1, Phase 2
36 Isoleucine Added ORS in Children With Diarrhoea Completed NCT01034228 Phase 2
37 Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection Completed NCT00485134 Phase 1, Phase 2
38 Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate Completed NCT01080716 Phase 1, Phase 2
39 Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity Completed NCT02354339 Phase 2
40 A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults Completed NCT02676895 Phase 2
41 Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a Completed NCT02646371 Phase 2
42 Therapeutic Induction of Endogenous Antibiotics Completed NCT00800930 Phase 2
43 Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine Completed NCT00210288 Phase 2
44 Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis. Completed NCT02265328 Phase 2
45 Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study Completed NCT01040325 Phase 2
46 Traveler's Diarrhea (TD) Automated Process Completed NCT00751777 Phase 2
47 Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea Completed NCT00098384 Phase 2 rifaximin
48 A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea Completed NCT00382304 Phase 2 tolevamer potassium-sodium (GT267-004)
49 A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea Completed NCT00034294 Phase 2 GT160-246
50 Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults Recruiting NCT03038243 Phase 2

Search NIH Clinical Center for Dysentery

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: dysentery

Genetic Tests for Dysentery

Anatomical Context for Dysentery

MalaCards organs/tissues related to Dysentery:

39
Colon, Testes, Liver, Neutrophil, Bone, Breast, Bone Marrow

Publications for Dysentery

Articles related to Dysentery:

(show top 50) (show all 563)
id Title Authors Year
1
Impact of meteorological factors on the incidence of bacillary dysentery in Beijing, China: A time series analysis (1970-2012). ( 28796834 )
2017
2
Projected burden of disease for bacillary dysentery due to flood events in Guangxi, China. ( 28605848 )
2017
3
An optimized swine dysentery murine model to characterize shedding and clinical disease associated with "Brachyspira hampsonii" infection. ( 28830508 )
2017
4
The Role of Probiotics in the Treatment of Dysentery: a Randomized Double-Blind Clinical Trial. ( 28321826 )
2017
5
Antibiotic Therapy for Acute Watery Diarrhea and Dysentery. ( 28885920 )
2017
6
Seasonal and geographical distribution of bacillary dysentery (shigellosis) and associated climate risk factors in Kon Tam Province in Vietnam from 1999 to 2013. ( 28637484 )
2017
7
Identification of weather variables sensitive to dysentery in disease-affected county of China. ( 27742060 )
2017
8
Antiprotozoal Constituents from Annona cherimola Miller, a Plant Used in Mexican Traditional Medicine for the Treatment of Diarrhea and Dysentery. ( 28216899 )
2017
9
Spatial-temporal detection of risk factors for bacillary dysentery in Beijing, Tianjin and Hebei, China. ( 28946856 )
2017
10
Environmental Drivers and Predicted Risk of Bacillary Dysentery in Southwest China. ( 28708077 )
2017
11
Treatment rates for injectable tiamulin and lincomycin as an estimate of morbidity in a swine herd with endemic swine dysentery. ( 28487591 )
2017
12
A cohort study of the effect of winter dysentery on herd-level milk production. ( 28601443 )
2017
13
The Effects of Floods on the Incidence of Bacillary Dysentery in Baise (Guangxi Province, China) from 2004 to 2012. ( 28208681 )
2017
14
The dysentery epidemic in Poland in 1920-1921 ( 28742314 )
2017
15
A novel multiplex qPCR targeting 23S rDNA for diagnosis of swine dysentery and porcine intestinal spirochaetosis. ( 28173799 )
2017
16
Impacts of ambient temperature on the burden of bacillary dysentery in urban and rural Hefei, China. ( 28294081 )
2017
17
Comparison of Brachyspira hyodysenteriae Isolates Recovered from Pigs in Apparently Healthy Multiplier Herds with Isolates from Herds with Swine Dysentery. ( 27489956 )
2016
18
Epidemiologic Investigation of Dysentery in North of Iran: Use of Geographic Information System (GIS). ( 28144197 )
2016
19
Lethality of First Contact Dysentery Epidemics on Pacific Islands. ( 27185765 )
2016
20
Anisakiasis Causing Acute Dysentery in Malaysia. ( 27325803 )
2016
21
Swine Dysentery: Etiopathogenesis and Diagnosis of a Reemerging Disease. ( 27288432 )
2016
22
Patterns of Bacillary Dysentery in China, 2005-2010. ( 26828503 )
2016
23
The Use of an Autoregressive Integrated Moving Average Model for Prediction of the Incidence of Dysentery in Jiangsu, China. ( 27106828 )
2016
24
Daily temperature change in relation to the risk of childhood bacillary dysentery among different age groups and sexes in a temperate city in China. ( 26655018 )
2016
25
Quantifying the Impact of Floods on Bacillary Dysentery in Dalian City, China, From 2004 to 2010. ( 27229186 )
2016
26
Efficacy of Synbiotics for Treatment of Bacillary Dysentery in Children: A Double-Blind, Randomized, Placebo-Controlled Study. ( 28042600 )
2016
27
Distributed lag effects and vulnerable groups of floods on bacillary dysentery in Huaihua, China. ( 27427387 )
2016
28
Neither plague nor malaria, but dysentery as a cause of death for St. Louis. ( 26759133 )
2016
29
The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014. ( 27863468 )
2016
30
Association between flood and the morbidity of bacillary dysentery in Zibo City, China: a symmetric bidirectional case-crossover study. ( 27121465 )
2016
31
Clinical study on the efficacy of Amoebex (coded herbal drug) compared with Metronidazole for the treatment of Amoebic dysentery. ( 28375117 )
2016
32
Association between meteorological factors and bacillary dysentery incidence in Chaoyang city, China: an ecological study. ( 27940632 )
2016
33
An Investigation into the Etiological Agents of Swine Dysentery in Australian Pig Herds. ( 27907102 )
2016
34
Quantitative analysis of burden of bacillary dysentery associated with floods in Hunan, China. ( 26780145 )
2016
35
Nonlinear and threshold of the association between meteorological factors and bacillary dysentery in Beijing, China. ( 26027678 )
2015
36
The association between diurnal temperature range and childhood bacillary dysentery. ( 26045331 )
2015
37
Trichuris dysentery syndrome: Do we learn enough from case studies? ( 26695216 )
2015
38
PREDICTING CLINICALLY DIAGNOSED DYSENTERY INCIDENCE OBTAINED FROM MONTHLY CASE REPORTING BASED ON METEOROLOGICAL VARIABLES IN DALIAN, LIAONING PROVINCE, CHINA, 2005-2011 USING A DEVELOPED MODEL. ( 26513932 )
2015
39
High mean water vapour pressure promotes the transmission of bacillary dysentery. ( 25946209 )
2015
40
Burden of major diarrheagenic protozoan parasitic co-infection among amoebic dysentery cases from North East India: a case report. ( 26099490 )
2015
41
Sequence types and pleuromutilin susceptibility of Brachyspira hyodysenteriae isolates from Italian pigs with swine dysentery: 2003-2012. ( 25486860 )
2015
42
The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery. ( 26068698 )
2015
43
Spatio-Temporal Pattern and Socio-Economic Factors of Bacillary Dysentery at County Level in Sichuan Province, China. ( 26469274 )
2015
44
Analysis of Risk and Burden of Dysentery Associated with Floods from 2004 to 2010 in Nanning, China. ( 26416103 )
2015
45
Misdiagnosed amoebic colitis leading to severe dysentery and necrotizing colitis--report of a case and review of the literature. ( 24450838 )
2014
46
Spatial-temporal pattern and risk factor analysis of bacillary dysentery in the Beijing-Tianjin-Tangshan urban region of China. ( 25257255 )
2014
47
Bacillary dysentery from World War 1 and NCTC1, the first bacterial isolate in the National Collection. ( 25441203 )
2014
48
Effect of zinc chelate and valnemulin for the treatment of swine dysentery in an experimental challenge study. ( 24287025 )
2014
49
Socio-economic factors of bacillary dysentery based on spatial correlation analysis in Guangxi Province, China. ( 25036182 )
2014
50
Isolation and development of bioluminescent reporter phages for bacterial dysentery. ( 25252629 )
2014

Variations for Dysentery

Expression for Dysentery

Search GEO for disease gene expression data for Dysentery.

Pathways for Dysentery

GO Terms for Dysentery

Cellular components related to Dysentery according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.61 ALB CD40LG CRP HP IFNA2 IL1A
2 extracellular space GO:0005615 9.32 ALB CD40LG CRP ENO2 HP IFNA2

Biological processes related to Dysentery according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.46 CD40LG CRP IFNA2 IL1A
2 B cell differentiation GO:0030183 9.13 CD40LG CD79A IFNA2
3 B cell proliferation GO:0042100 8.8 CD40LG CD79A IFNA2

Sources for Dysentery

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....